Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation "ARISTOTLE"


Phase 3 Results

Summary of Purpose

The trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner) is as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in subjects with atrial fibrillation and risk factors for stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 September 2013.

1 Dec 2006 18 Dec 2006 1 Jun 2011 1 Jun 2011 1 Sep 2013 25 Jan 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


Not available